Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells

被引:222
作者
Iovino, L. [1 ]
Tremblay, M. E. [2 ]
Civiero, L. [1 ,3 ]
机构
[1] Univ Padua, Dept Biol, Padua, Italy
[2] Univ Victoria, Div Med Sci, Victoria, BC, Canada
[3] IRCCS San Camillo Hosp, Venice, Italy
关键词
Parkinson's disease; Glutamate-induced excitotoxicity; Inflammation; Astrocytes; Microglia; TUMOR-NECROSIS-FACTOR; ANTIPORTER SYSTEM X(C)(-); TIME-DEPENDENT CHANGES; ALPHA-SYNUCLEIN; LRRK2; G2019S; MOUSE MODEL; MICROGLIAL ACTIVATION; L-DOPA; REACTIVE ASTROCYTES; RECEPTORS PROTECTS;
D O I
10.1016/j.jphs.2020.07.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate transmission efficiency depends on the correct functionality and expression of a plethora of receptors and transporters, located both on neurons and glial cells. Of note, glutamate reuptake by dedicated transporters prevents its accumulation at the synapse as well as non-physiological spillover. Indeed, extracellular glutamate increase causes aberrant synaptic signaling leading to neuronal excitotoxicity and death. Moreover, extrasynaptic glutamate diffusion is strongly associated with glia reaction and neuroinflammation. Glutamate-induced excitotoxicity is mainly linked to an impaired ability of glial cells to reuptake and respond to glutamate, then this is considered a common hallmark in many neurodegenerative diseases, including Parkinson's disease (PD). In this review, we discuss the function of astrocytes and microglia in glutamate homeostasis, focusing on how glial dysfunction causes glutamate-induced excitotoxicity leading to neurodegeneration in PD. (C) 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.
引用
收藏
页码:151 / 164
页数:14
相关论文
共 177 条
  • [61] The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with L-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease
    Jones, Carrie K.
    Bubser, Michael
    Thompson, Analisa D.
    Dickerson, Jonathan W.
    Turle-Lorenzo, Nathalie
    Amalric, Marianne
    Blobaum, Anna L.
    Bridges, Thomas M.
    Morrison, Ryan D.
    Jadhav, Satyawan
    Engers, Darren W.
    Italiano, Kimberly
    Bode, Jacob
    Daniels, J. Scott
    Lindsley, Craig W.
    Hopkins, Corey R.
    Conn, P. Jeffrey
    Niswender, Colleen M.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (02) : 404 - 421
  • [62] MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats
    Jonkers, N
    Sarre, S
    Ebinger, G
    Michotte, Y
    [J]. BRAIN RESEARCH, 2002, 926 (1-2) : 149 - 155
  • [63] NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats
    Kelsey, JE
    Mague, SD
    Pijanowski, RS
    Harris, RC
    Kleckner, NW
    Matthews, RT
    [J]. PSYCHOPHARMACOLOGY, 2004, 175 (02) : 179 - 188
  • [64] Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
    Kim, Beomsue
    Yang, Myung-Soon
    Choi, Dongjoo
    Kim, Jong-Hyeon
    Kim, Hye-Sun
    Seol, Wongi
    Choi, Sangdun
    Jou, Ilo
    Kim, Eun-Young
    Joe, Eun-Hye
    [J]. PLOS ONE, 2012, 7 (04):
  • [65] DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression
    Kim, Jin-Mo
    Cha, Seon-Heui
    Choi, Yu Ree
    Jou, Ilo
    Joe, Eun-Hye
    Park, Sang Myun
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [66] Role of Excitatory Amino Acid Transporter-2 (EAAT2) and Glutamate in Neurodegeneration: Opportunities for Developing Novel Therapeutics
    Kim, Keetae
    Lee, Seok-Geun
    Kegelman, Timothy P.
    Su, Zhao-Zhong
    Das, Swadesh K.
    Dash, Rupesh
    Dasgupta, Santanu
    Barral, Paola M.
    Hedvat, Michael
    Diaz, Paul
    Reed, John C.
    Stebbins, John L.
    Pellecchia, Maurizio
    Sarkar, Devanand
    Fisher, Paul B.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2011, 226 (10) : 2484 - 2493
  • [67] Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity
    Kirkley, Kelly S.
    Popichak, Katriana A.
    Afzali, Maryam F.
    Legare, Marie E.
    Tjalkens, Ronald B.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2017, 14
  • [68] THE AMPA RECEPTOR ANTAGONIST NBQX HAS ANTIPARKINSONIAN EFFECTS IN MONOAMINE-DEPLETED RATS AND MPTP-TREATED MONKEYS
    KLOCKGETHER, T
    TURSKI, L
    HONORE, T
    ZHANG, ZM
    GASH, DM
    KURLAN, R
    GREENAMYRE, JT
    [J]. ANNALS OF NEUROLOGY, 1991, 30 (05) : 717 - 723
  • [69] Physiology and Pharmacology of Striatal Neurons
    Kreitzer, Anatol C.
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2009, 32 : 127 - 147
  • [70] Microglial Implication in Parkinson's Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
    Lecours, Cynthia
    Bordeleau, Maude
    Cantin, Leo
    Parent, Martin
    Di Paolo, Therese
    Tremblay, Marie-Eve
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12